ScripNews that US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) director Peter Marks submitted his resignation, effective 5 April, late in the day on 28 March shook the b
ScripA partnership with French drug maker Sanofi, leveraging its platform and pipeline to find new partnerships, and advancing the pipeline form the three main strategic priorities for Novavax as it works
In VivoBiopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Pink SheetThe US Food and Drug Administration’s approval of two new vaccines places the spotlight on what would normally be a routine next step on the road to market, the US Center for Disease Control and Preve